ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,341,830 | -31.9% | 151,215 | -46.0% | 0.43% | -32.3% |
Q2 2023 | $109,186,367 | +4.6% | 280,159 | 0.0% | 0.63% | +11.3% |
Q1 2023 | $104,381,640 | -1.6% | 280,159 | 0.0% | 0.57% | -10.8% |
Q4 2022 | $106,132,634 | +7.3% | 280,159 | 0.0% | 0.64% | -1.7% |
Q3 2022 | $98,910,000 | -76.7% | 280,159 | -75.0% | 0.65% | -73.1% |
Q2 2022 | $424,178,000 | +20.2% | 1,119,557 | 0.0% | 2.41% | +18.6% |
Q1 2022 | $353,008,000 | -10.0% | 1,119,557 | 0.0% | 2.03% | +6.3% |
Q4 2021 | $392,058,000 | +16.0% | 1,119,557 | 0.0% | 1.91% | +28.4% |
Q3 2021 | $338,106,000 | +0.3% | 1,119,557 | 0.0% | 1.48% | +0.3% |
Q2 2021 | $337,065,000 | +9.3% | 1,119,557 | 0.0% | 1.48% | +10.7% |
Q1 2021 | $308,315,000 | +2.8% | 1,119,557 | +9.8% | 1.34% | +18.3% |
Q4 2020 | $299,842,000 | +12.0% | 1,019,557 | 0.0% | 1.13% | +5.6% |
Q3 2020 | $267,654,000 | +16.6% | 1,019,557 | 0.0% | 1.07% | +5.6% |
Q2 2020 | $229,635,000 | +71.0% | 1,019,557 | 0.0% | 1.01% | +22.5% |
Q1 2020 | $134,306,000 | -17.9% | 1,019,557 | 0.0% | 0.83% | -4.9% |
Q4 2019 | $163,659,000 | +40.9% | 1,019,557 | 0.0% | 0.87% | +10.1% |
Q3 2019 | $116,189,000 | -19.5% | 1,019,557 | 0.0% | 0.79% | -19.5% |
Q2 2019 | $144,349,000 | +13.4% | 1,019,557 | 0.0% | 0.98% | +20.4% |
Q1 2019 | $127,281,000 | +29.9% | 1,019,557 | 0.0% | 0.82% | +1.6% |
Q4 2018 | $97,949,000 | +26.7% | 1,019,557 | 0.0% | 0.80% | +57.6% |
Q3 2018 | $77,323,000 | -3.0% | 1,019,557 | +6.0% | 0.51% | -15.0% |
Q2 2018 | $79,691,000 | +3.0% | 961,754 | 0.0% | 0.60% | -8.7% |
Q1 2018 | $77,363,000 | +27.4% | 961,754 | 0.0% | 0.66% | +24.7% |
Q4 2017 | $60,725,000 | +2585.8% | 961,754 | +861.8% | 0.53% | +2822.2% |
Q3 2017 | $2,261,000 | +6.6% | 100,000 | 0.0% | 0.02% | -5.3% |
Q2 2017 | $2,121,000 | – | 100,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |